Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-27

Clinical Trial Update: Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating hydroxyurea, omega-3, Nigella sativa, and honey for iron overload and oxidative stress in pediatric major thalassemia; study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Honey
  • Hydroxy Urea (hydroxyurea)
  • Nigella Sativa (Nigella sativa)
  • Omega-3 (omega-3 fatty acids)

Snippet

Sponsor: Beni-Suef University | Conditions: Iron Overload, Oxidative Stress | Phase 2, Phase 3 | Status: COMPLETED